Taibang Biologic Group Transaction

Convertible Investment New Security Issue in China, Asia

Transaction Details

Name:Taibang Biologic Group
Amount:Available on swfi.com
Announced At:08/02/2022
Closed At:08/02/2022
RegionAsia
Country:China
Type:New Security Issue
Security Type:Convertible Preferred Stock
Investment Type:Convertible
SectorHealthcare
Industry:Biotechnology
Summary:Available

Buyers

Entity 1
Sovereign Wealth Fund in Singapore		Stake
Available on swfi.com